QuiVad

Home / United Kingdom / Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 6.51% on July 19, 2017. The shaded band matches the twelve months of the first chart.

November 1, 2012 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Hikma Pharmaceuticals PLC by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

266 disclosures on record for this share.
DateFund% of capitalEnd of publication
June 11, 2018Capital Fund Management SA0.60%
June 8, 2018Marshall Wace LLP0.60%
June 8, 2018AQR Capital Management, LLC0.49%
June 7, 2018Marshall Wace LLP0.59%
June 7, 2018Capital Fund Management SA0.58%
May 21, 2018Marshall Wace LLP0.80%
May 21, 2018AKO Capital LLP FOR AKO Master Fund Limited0.49%
May 18, 2018AKO Capital LLP FOR AKO Master Fund Limited0.52%
May 17, 2018AQR Capital Management, LLC0.59%
May 16, 2018Marshall Wace LLP0.70%
May 2, 2018Jpmorgan Asset Management (UK) LTD0.45%
May 1, 2018Marshall Wace LLP0.60%
April 27, 2018AQR Capital Management, LLC0.69%
April 17, 2018Marshall Wace LLP0.50%
April 12, 2018AQR Capital Management, LLC0.79%
April 12, 2018AKO Capital LLP FOR AKO Master Fund Limited0.61%
April 9, 2018Jpmorgan Asset Management (UK) LTD0.57%
April 3, 2018AQR Capital Management, LLC0.89%
March 22, 2018AQR Capital Management, LLC0.96%
March 15, 2018Jpmorgan Asset Management (UK) LTD0.68%
March 12, 2018Jpmorgan Asset Management (UK) LTD0.71%
March 5, 2018AQR Capital Management, LLC1.08%
March 1, 2018Capital Fund Management SA0.69%
February 26, 2018AKO Capital LLP FOR AKO Master Fund Limited0.54%
February 20, 2018AKO Capital LLP FOR AKO Master Fund Limited0.61%
February 15, 2018AQR Capital Management, LLC1.19%
February 2, 2018AQR Capital Management, LLC1.28%
January 22, 2018AQR Capital Management, LLC1.38%
January 8, 2018AQR Capital Management, LLC1.49%
January 4, 2018Jpmorgan Asset Management (UK) LTD0.69%
December 22, 2017AQR Capital Management, LLC1.59%
December 15, 2017Marshall Wace LLP0.49%
December 14, 2017Capital Fund Management SA0.79%
December 14, 2017Marshall Wace LLP0.55%
December 13, 2017AQR Capital Management, LLC1.68%
December 11, 2017Marshall Wace LLP0.67%
December 7, 2017Marshall Wace LLP0.73%
December 6, 2017Marshall Wace LLP0.87%
December 5, 2017Marshall Wace LLP0.95%
December 1, 2017AQR Capital Management, LLC1.79%
December 1, 2017Marshall Wace LLP1.07%
November 30, 2017Marshall Wace LLP1.14%
November 30, 2017Millennium International Management LP0.00%
November 29, 2017Millennium International Management LP0.95%
November 28, 2017Marshall Wace LLP1.27%
November 27, 2017Millennium International Management LP0.80%
November 22, 2017Marshall Wace LLP1.33%
November 21, 2017Jpmorgan Asset Management (UK) LTD0.59%
November 20, 2017AQR Capital Management, LLC1.88%
November 17, 2017Jpmorgan Asset Management (UK) LTD0.65%

Download 266 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United Kingdom

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Hikma Pharmaceuticals PLC, source FCA, data as at September 19, 2019, https://www.quivad.com/action/hikma-pharmaceuticals-plc?page=2